SpineFrontier, with its focus on LES (Less Exposure Surgery), is uniquely positioned to take advantage of the growing movement toward outpatient surgery. Dr. Chin’s techniques allow patients to walk out of spine surgery within hours.
Boston, MA (PRWEB) January 21, 2016
SpineFrontier (http://www.spinefrontier.com) announced today that Jerry Goldstein, Founder and former CEO of Advanced Magnetics (AMAG), has joined the SpineFrontier Board of Directors. Jerry is a pioneer in the MRI industry. He started AMAG in 1981 and took the company public in 1986. AMAG is best known for its MR imaging agents and iron deficiency therapeutics.
“Jerry’s experience will be extraordinarily valuable to our company over the next few years. We are looking forward to his guidance in preparing and taking our companies public,” said Dr. Kingsley Chin, CEO of KICVentures and SpineFrontier.
Goldstein has four degrees from MIT: a B.S. in materials science, an M.S. in metallurgical engineering, a Metallurgical Engineer's Degree and an M.S. in management.
“SpineFrontier, with its focus on LES (Less Exposure Surgery), is uniquely positioned to take advantage of the growing movement toward outpatient surgery. Dr. Chin’s techniques allow patients to walk out of spine surgery within hours,” said Jerry Goldstein. “The LES movement is helping to lower costs, improve patient recovery times and put surgeons back in control of patient care. I’m excited to be part of this.”
About SpineFrontier® Inc.
SpineFrontier Inc. (http://www.spinefrontier.com) is a growing medical technology company that designs, develops and markets both implants and instruments for spine surgery based on the Less Exposure Surgery (LES®) Philosophy. These technologies are designed to allow for outpatient surgery due to minimal disruption of normal tissues. SpineFrontier is headquartered in Malden, MA. It is a KICVentures portfolio company and the leader in LES technologies and instruments.
About Less Exposure Surgery
Less Exposure Surgery (LES®) is based on a new philosophy of performing surgery. LES® is less invasive than MIS. By developing improved technologies and techniques tailored for pinpointing a problem and fixing it without collateral damage, LES® minimizes tissue disruption.
KICVentures (http://www.KICVentures.com) manages several portfolio companies, investing in disruptive technology in the health-tech sector. KICVentures acquires, creates, and nurtures companies and their technologies to their fullest potential.